Skip to main content

Table 4 Physicians' reports of how they use CHD global risk assessment for primary prevention, among those who use CHD risk assessment (N = 358)

From: Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians

 

All

Family Physicians

General Internists

Cardiologists

P- value*

 

%

%

%

%

 

Use global CHD risk estimate to guide lipid lowering therapy recommendations (n = 355)

69.0

63.5

72.4

73.3

0.16

Use global CHD risk estimate to guide aspirin therapy recommendations (n = 350)

53.7

52.4

51.4

56.5

0.72

Use global CHD risk estimate to guide blood pressure lowering therapy recommendations (n = 356)

48.3

48.7

44.7

50.0

0.76

Use global CHD risk estimate to guide any primary prevention therapy recommendation (n = 358) †

76.8

73.2

79.0

79.7

0.38

Tell patients their global CHD risk (n = 352)

40.1

37.7

33.0

49.2

0.01

  1. CHD = coronary heart disease
  2. *Overall p-values based on Pearson's chi squared test for significance between specialty groups
  3. † Based on using risk estimate to guide lipid lowering, aspirin, or blood pressure lowering recommendation